Success Metrics

Clinical Success Rate
97.3%

Based on 108 completed trials

Completion Rate
97%(108/111)
Active Trials
72(27%)
Results Posted
25%(27 trials)
Terminated
3(1%)

Phase Distribution

Ph early_phase_1
1
0%
Ph phase_2
15
6%
Ph phase_3
4
1%
Ph not_applicable
236
87%
Ph phase_1
10
4%
Ph phase_4
4
1%

Phase Distribution

11

Early Stage

15

Mid Stage

8

Late Stage

Phase Distribution270 total trials
Early Phase 1First-in-human
1(0.4%)
Phase 1Safety & dosage
10(3.7%)
Phase 2Efficacy & side effects
15(5.6%)
Phase 3Large-scale testing
4(1.5%)
Phase 4Post-market surveillance
4(1.5%)
N/ANon-phased studies
236(87.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

89.3%

108 of 121 finished

Non-Completion Rate

10.7%

13 ended early

Currently Active

72

trials recruiting

Total Trials

271

all time

Status Distribution
Active(109)
Completed(108)
Terminated(13)
Other(41)

Detailed Status

Completed108
Recruiting69
unknown40
Not yet recruiting33
Withdrawn10
Enrolling by invitation4

Development Timeline

Analytics

Development Status

Total Trials
271
Active
72
Success Rate
97.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.4%)
Phase 110 (3.7%)
Phase 215 (5.6%)
Phase 34 (1.5%)
Phase 44 (1.5%)
N/A236 (87.4%)

Trials by Status

completed10840%
unknown4015%
suspended10%
not_yet_recruiting3312%
active_not_recruiting31%
withdrawn104%
terminated31%
recruiting6925%
enrolling_by_invitation41%

Recent Activity

Clinical Trials (271)

Showing 20 of 271 trialsScroll for more
NCT07442058Not Applicable

Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD

Not Yet Recruiting
NCT07219719Phase 1

Temporal Interference for Thalamocortical Activity and Network Modulation

Recruiting
NCT07520955Not Applicable

Lily's Grace Temporal Interference

Not Yet Recruiting
NCT07680153Phase 4

Neuromodulation of Mood Switch Circuitry in Bipolar Disorder

Recruiting
NCT07834658Not Applicable

Effects of Transcutaneous Tibial and Auricular Vagus Nerve Stimulation in Females With Primary Dysmenorrhea

Not Yet Recruiting
NCT07831525Not Applicable

Effect of Different Currents for Transcranial Modulation of the Sensorimotor Corticospinal Pathway in Healthy Subjects

Enrolling By Invitation
NCT07105358Not Applicable

Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training

Recruiting
NCT07549243Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation for Preventing Acute Kidney Injury in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Recruiting
NCT03304600Not Applicable

tDCS for Treatment Resistant Obsessive Compulsive Disorder

Completed
NCT06608680Not Applicable

Timing and Facilitation Effects of Theta-Burst Stimulation in the Reading and Language Networks

Recruiting
NCT07795554Not Applicable

The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain

Not Yet Recruiting
NCT07574268Phase 4

Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men With Erectile Dysfunction: A Randomized, Double-Blind, Bi-centric, Placebo- and Sham-Controlled Trial

Completed
NCT07553364Not Applicable

Auditory Stimulation for Insomnia and Depression

Withdrawn
NCT07777991Not Applicable

Stimulation Evaluation for Neuromodulation Sensory Effects

Not Yet Recruiting
NCT07775586Not Applicable

Home-Based Wearable rTMS Therapy for Moderate to Severe Depression

Not Yet Recruiting
NCT07000214Phase 2

Peripheral Magnetic Stimulation With Balance Training to Decrease Fall Risks in Diabetic Polyneuropathy

Recruiting
NCT07758348Not Applicable

Investigating Modulation of Neuropathic Pain by Transcranial Magnetic Stimulation: a Multimodal Imaging and Electrophysiological Approach

Not Yet Recruiting
NCT04870255Not Applicable

Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS

Recruiting
NCT06003036Not Applicable

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine

Completed
NCT05794295Not Applicable

Sleep Architecture & Cognition in Focal Epilepsy

Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
271